trial · primary record
QLS2416 Injection
Systemic Lupus Erythematosus
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 76 |
| Primary completion | 2029-12 |
| Primary endpoint | Safety and Tolerability of QLS2416 Injection |
| Registry ID | NCT07906145 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:40:38.234Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07906145
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.